Deals > All

France Monaco Central France Eastern France Northern France Paris (region) Southern France Western France

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1308 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Deal: Collaboration or Financing	Date
iOmx Therapeutics–SEVERAL: investment, 202110 financing round Series B €65m co-led by Athos Service GmbH + MIG Capital AG	2021-10-05
Pierre Fabre–Atara Biotherapeutics: tabelecleucel, 202110– collab $45m upfront + $320m milestones + royalties excl sales in EMEA for EBV+ cancers	2021-10-04
Aglaia Therapeutics–Advent France Biotechnology: investment, 202109 seed financing round totalling €4m incl co-founder + lead investor AFB	2021-09-27
Aglaia Therapeutics–Crédit Mutuel-CIC: investment, 202109 seed financing round totalling €4m incl co-investor Crédit Mutuel Innovation	2021-09-27
Aglaia Therapeutics–Pierre Fabre: investment, 202109 seed financing round totalling €4m incl co-investor Pierre Fabre	2021-09-27
Aglaia Therapeutics–SEVERAL: investment, 202109 seed financing round €4m led by Advent FB with Crédit Mutuel Innovation + Pierre Fabre	2021-09-27
Jeito Capital–SEVERAL: investment, 202109 final closing Jeito I with addit €284m at €534m after €200m 1st close + €50m from Sanofi	2021-09-20
Clean Biologics–Andrew Lloyd Associates: public relations, 202109 service existent for Clean Cells by ALA	2021-09-15
Clean Biologics–ArchiMed: investment, 202109 investment existent by ArchiMed	2021-09-15
TreeFrog Therapeutics–BMS: investment, 202109 financing round Series B totalling $75m (€64m) incl co-investor BMS	2021-09-13
TreeFrog Therapeutics–France (govt): investment, 202109 financing round Series B totalling $75m (€64m) incl lead investor Bpifrance Large Venture	2021-09-13
TreeFrog Therapeutics–Leonard Green: investment, 202109 financing round Series B totalling $75m (€64m) incl co-investor Leonard Green + Partners LP	2021-09-13
TreeFrog Therapeutics–SEVERAL: investment, 202109 financing round Series B $75m (€64m) led by Bpifrance Large Venture	2021-09-13
TreeFrog Therapeutics–Siparex: investment, 202109 financing round Series B totalling $75m (€64m) incl exisiting + co-investor XAnge	2021-09-13
Tissium–Cathay Capital: investment, 202108 financing round Series C totalling €50m incl new + co-lead investor Cathay Health	2021-08-31
Tissium–SEVERAL: investment, 202108 financing round Series C €50m co-led by Cathay Health + Sofinnova Partners	2021-08-31
Tissium–Sofinnova: investment, 202108 financing round Series C totalling €50m incl existing + co-lead investor Sofinnova Partners	2021-08-31
Afyren–SEVERAL: investment, 202108– IPO at Euronext Growth Paris registration document filed	2021-08-25
Translate Bio–Sanofi: investment, 202108– cash tender offer $3.2b at $38/share ANNOUNCED	2021-08-03
T-Knife–SEVERAL: investment, 202108 financing round Series B $110m led by new investor Fidelity Management and Research	2021-08-02
Xell AG–Sartorius: investment, 202107 acquisition €50m plus two revenue-based earn-out components in 2022 to 2025	2021-07-29
France (govt)–Jeito Capital: business development, 202107– supply service Rafaèle Tordjman appointed to promote French biotech ecosystem	2021-07-28
Artios Pharma–SEVERAL: investment, 202107 financing round Series C £110m ($153m) co-led by Omega Funds + TCG X	2021-07-27
Abivax–SEVERAL: credit, 202107– convertible bonds €25m at 6% interest/year	2021-07-23
Abivax–SEVERAL: investment, 202107 capital increase €60m with 3% discount with 1.97m shares at €30.55/share	2021-07-23
Voluntis–Aptar: investment, 202106– cash tender offer €78.8m at €8.7/share announced with 64.6% committed by reference shareholders	2021-07-23
Coave Therapeutics–Eurazeo: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Idinvest	2021-07-21
Coave Therapeutics–eureKARE: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor eureKARE	2021-07-21
Coave Therapeutics–Fund+: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Fund+	2021-07-21
Coave Therapeutics–GO Capital (FR): investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor GO Capital	2021-07-21
Coave Therapeutics–Huntsworth: public relations, 202107 service existent by Medistrava Consulting	2021-07-21
Coave Therapeutics–Kurma Partners: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Kurma Partners	2021-07-21
Coave Therapeutics–Omnes Capital: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Omnes Capital	2021-07-21
Coave Therapeutics–Seroba: investment, 202107 financing round Series B extension totalling €21.2m incl lead investor Seroba Life Sciences	2021-07-21
Coave Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €21.2m bringing total Series B to €33.1m	2021-07-21
Coave Therapeutics–Sham: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Sham Innovation Santé	2021-07-21
Coave Therapeutics–Théa Open Innovation: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor Théa OI	2021-07-21
Coave Therapeutics–V-Bio Ventures: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor V-Bio Ventures	2021-07-21
Dopavision–Akampion: public relations, 202107 service existent by Akampion	2021-07-14
Dopavision–Boehringer: investment, 202107 financing round Series A totalling €12m incl existing + co-investor BIVF	2021-07-14
Dopavision–BPCE: investment, 202107 financing round Series A totalling €12m incl new + lead investor Seventure Partners	2021-07-14
Dopavision–Eternity.Health: investment, 202107 financing round Series A totalling €12m incl existing + co-investor Ababax Health	2021-07-14
Dopavision–Novartis: investment, 202107 financing round Series A totalling €12m incl new + co-investor Novartis Pharmaceuticals	2021-07-14
Dopavision–SEVERAL: investment, 202107 financing round Series A €12m led by new investor Seventure Partners	2021-07-14
Sofinnova–SEVERAL: investment, 202107 closing €63m of Sofinnova MD Start III fund	2021-07-13
Micropep Technologies–CEA Industrie: investment, 202107 financing round Series A totalling €8.5m incl new + lead investor Supernova Invest	2021-07-08
Micropep Technologies–FMC: investment, 202107 financing round Series A totalling €8.5m incl new + co-investor FMC Ventures	2021-07-08
Micropep Technologies–Irdi Soridec: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor Irdi Capital	2021-07-08
Micropep Technologies–SEVERAL: investment, 202107 financing round Series A €8.5m led by Supernova Invest	2021-07-08
Micropep Technologies–Sofinnova: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor Sofinnova Partners	2021-07-08
CellGenix–Sartorius: investment, 202107 acquisition 51% share for €100m cash by SSB with planned acquisition of remaining shares until 2026	2021-07-02
NFL Biosciences–SEVERAL: investment, 202106–202107 IPO €5m at Euronext Growh Paris with 486.2k shares in France + 829.6k shares globally at €3.8/share	2021-06-30
Xenothera–EU (govt): investment, 202106 financing round totalling €20m incl €10m from new + lead investor EIC Fund	2021-06-29
Xenothera–SEVERAL: investment, 202106 financing round €20m led by new investor EIC Fund with €10m	2021-06-29
Pixium Vision–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Pixium Vision	2021-06-25
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool	2021-06-22
Corlieve Therapeutics–Uniqure: investment, 202106–202107 acquisition €46.3m upfront cash + €203.7m milestones	2021-06-22
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED	2021-06-22
Mnemo Therapeutics–Alexandria Real Estate: investment, 202106 financing round Series A totalling €75m incl co-investor Alexandria Venture Investments	2021-06-16
Mnemo Therapeutics–Casdin Capital: investment, 202106 financing round Series A totalling €75m incl co-lead investor Casdin Capital	2021-06-16
Mnemo Therapeutics–Emerson Collective: investment, 202106 financing round Series A totalling €75m incl co-investor Emerson Collective	2021-06-16
Mnemo Therapeutics–OTHER: investment, 202106 financing round Series A totalling €75m incl co-lead by undisclosed investor	2021-06-16
Mnemo Therapeutics–Redmile Group: investment, 202106 financing round Series A totalling €75m incl co-investor Redmile Group	2021-06-16
Mnemo Therapeutics–SEVERAL: investment, 202106 financing round Series A €75m led by Casdin Capital + Sofinnova Partners + NN	2021-06-16
Mnemo Therapeutics–Sofinnova: investment, 202106 financing round Series A totalling €75m incl existing + co-lead investor Sofinnova Partners	2021-06-16
Alentis Therapeutics–Bellevue: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BB Pureos Bioventures	2021-06-15
Alentis Therapeutics–BioMedPartners: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BioMed Partners	2021-06-15
Alentis Therapeutics–France (govt): investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Bpifrance InnoBio 2 Fund	2021-06-15
Alentis Therapeutics–High-Tech Gründerfonds: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor HTGF	2021-06-15
Alentis Therapeutics–Jeito Capital: investment, 202106 financing round Series B totalling CHF60m incl new + co-investor Jeito Capital	2021-06-15
Alentis Therapeutics–Morningside: investment, 202106 financing round Series B totalling CHF60m incl new + lead investor Morningside Ventures	2021-06-15
Alentis Therapeutics–Schroders: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Schroders Capital	2021-06-15
Alentis Therapeutics–SEVERAL: investment, 202106 financing round Series B CHF60m led by Morningside Venture Investments	2021-06-15
HiFiBio–B Capital Group: investment, 202106 financing round Series D totalling $75m incl new + co-investor B Capital Group	2021-06-14
HiFiBio–Grand Mount: investment, 202106 financing round Series D totalling $75m incl new + co-investor Grand Mount	2021-06-14
HiFiBio–Hengxu: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Hengxu	2021-06-14
HiFiBio–HKSTP Venture Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor HKSTP Venture Fund	2021-06-14
HiFiBio–IDG Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor IDG	2021-06-14
HiFiBio–Legend Star Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Legend Star	2021-06-14
HiFiBio–Maison Capital: investment, 202106 financing round Series D totalling $75m incl new + co-investor Maison Capital	2021-06-14
HiFiBio–Mirae Asset: investment, 202106 financing round Series D totalling $75m incl new + lead investor Mirae Asset Capital	2021-06-14
HiFiBio–Sequoia Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Sequoia Capital China	2021-06-14
HiFiBio–SEVERAL: investment, 202106 financing round Series D $75m led by new investor Mirae Asset Capital	2021-06-14
HiFiBio–Sherpa Healthcare Partners: investment, 202106 financing round Series D totalling $75m incl new + co-investor Sherpa Healthcare Partners	2021-06-14
HiFiBio–Trinity Innovation Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor TIF	2021-06-14
Advent France Biotechnology–Andrew Lloyd Associates: public relations, 202106 service existent by ALA	2021-06-08
AB Science–Alpha Blue Ocean: investment, before 202106 investment by ABO	2021-06-07
Erytech–Alpha Blue Ocean: investment, before 202106 investment by ABO	2021-06-07
Intrasense–Alpha Blue Ocean: investment, before 202106 investment by ABO	2021-06-07
Pharnext–Alpha Blue Ocean: credit, 202106–202405 convertible bond program up to €81m in 35 tranches with Global Tech Opportunities 13	2021-06-04
Amyl Therapeutics–Mérieux: investment, 202106 financing round Series A totalling €8.6m incl co-investor Mérieux Participations	2021-06-03
Amyl Therapeutics–SEVERAL: investment, 202106 financing round Series A €8.6m led by Noshaq	2021-06-03
L’Oréal–Celonis: management execution software, 202106 supply existent customer L’Oréal	2021-06-02
HalioDx–Veracyte: investment, 202106– acquisition €147m in cash + €113m in stock ANNOUNCED	2021-06-01
Pulmocide–Jeito Capital: investment, 202105 financing round Series C totalling $92m incl new + lead investor Jeito Capital	2021-05-27
Pulmocide–SEVERAL: investment, 202105 financing round Series C $92m led by new investor Jeito Capital	2021-05-27
Swixx Biopharma–Mérieux: investment, 202105– capital increase totalling €45m incl €40m for minority share from new investor MxEP	2021-05-20
Swixx Biopharma–SEVERAL: investment, 202105– capital increase €45m with €40m from new investor MxEP + €5m from existing investor HBM	2021-05-20
Cytoki Pharma–SEVERAL: investment, 202105 financing round Series A $45m led by existing investor Lundbeckfonden Emerge	2021-05-05
MoonLake–Merck (DE): sonelokimab, 202105– license from Merck KGaA	2021-05-03

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)